Closing our second round of investment funding
We’re so excited to announce that we’ve closed our second funding round 🎉
This funding will see us well into our plans to launch at the start of 2023, as well as to grow and scale far beyond.
A huge thank you to all our incredible angel investors that have joined us on our journey - as first time founders James and I relish having such an amazing network of advice and support to pull on from individuals with a huge depth of experience across a wide breadth of industries.
We raised above and beyond our targets and have already begun putting it to good use, investing as a business into large scale production of our Anaphylaxis Kitts (amongst many other exciting developments).
As a recap - After working with a handful of schools across England last year to develop, test and iterate our pilot product ‘ana.’ - we finalised the design of our Kitts with our partners Duku Design, along with an exciting rebrand to Kitt Medical!
We’ve now been working hard with our manufacturing partners, Iota Sigma, to produce our Kitts, and will soon be able to deliver them quickly and effectively, right here within the UK!
In fact - We drove over to Wales last week to see the first product sample batch ourselves 👀
The Kitt Medical team with our manufacturing partners testing the first Anaphylaxis Kitt samples!
It was an amazing experience, both as a founder and product designer, to see my original university student dream become a tangible reality.
As we build towards launching into schools nationwide, we’re now only a few months away from making a positive impact to so many lives.
